Meers Paul R
Department of Plant Biology, School of Environmental and Biological Sciences, Rutgers University, New Brunswick, NJ, USA.
J Membr Biol. 2022 Oct;255(4-5):523-535. doi: 10.1007/s00232-021-00210-0. Epub 2022 Jan 11.
Small molecule antibiotics are often derived from microorganisms that thrive in competitive environments. Their importance as therapeutics for infectious disease in humans has been established over many years. It has now become clear that antibiotic-producing organisms use packaging and delivery in the form of vesicles in many cases. A similar strategy has evolved in recent decades in the pharmaceutical industry for formulation of antibiotic therapies. The top-down approach that has evolved over millions of years in various micro-organisms has generated complex, efficient delivery systems that we are just now beginning to understand. The bottom-up formulation approach involves simple, safe compositions, which are being continually enhanced by trying to add features of which the natural systems inform us. A comparison is made here of these paradigms. Despite the differences, there are a number of common features in the basic physical and biological requirements that must be satisfied. In this review, illustration and comparison of some of these requirements is given, demonstrating the ongoing challenges in this area of research.
小分子抗生素通常来源于在竞争环境中茁壮成长的微生物。多年来,它们作为人类传染病治疗药物的重要性已得到确立。现在已经清楚的是,在许多情况下,产生抗生素的生物体以囊泡的形式进行包装和递送。近几十年来,制药行业在抗生素疗法的配方设计中也采用了类似的策略。在各种微生物中历经数百万年演变而来的自上而下的方法,产生了复杂而高效的递送系统,而我们直到现在才开始理解这些系统。自下而上的配方设计方法涉及简单、安全的成分,通过尝试添加自然系统启发我们的特性,这些成分正在不断得到改进。本文对这些模式进行了比较。尽管存在差异,但在必须满足的基本物理和生物学要求方面有许多共同特征。在本综述中,对其中一些要求进行了举例说明和比较,展示了该研究领域当前面临的挑战。